Haemophilia B: database of point mutations and short additions and deletions.
作者信息
Giannelli F, Green P M, High K A, Lozier J N, Lillicrap D P, Ludwig M, Olek K, Reitsma P H, Goossens M, Yoshioka A
机构信息
Paediatric Research Unit, Guy's Tower, London Bridge, London, UK.
出版信息
Nucleic Acids Res. 1990 Jul 25;18(14):4053-9. doi: 10.1093/nar/18.14.4053.
Abstract
摘要
相似文献
1
Haemophilia B: database of point mutations and short additions and deletions.
Nucleic Acids Res. 1990 Jul 25;18(14):4053-9. doi: 10.1093/nar/18.14.4053.
2
Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.
Nucleic Acids Res. 1994 Sep;22(17):3534-46. doi: 10.1093/nar/22.17.3534.
3
Haemophilia B: database of point mutations and short additions and deletions, 7th edition.
Nucleic Acids Res. 1997 Jan 1;25(1):133-5. doi: 10.1093/nar/25.1.133.
4
Haemophilia B: database of point mutations and short additions and deletions--eighth edition.
Nucleic Acids Res. 1998 Jan 1;26(1):265-8. doi: 10.1093/nar/26.1.265.
5
Haemophilia B (sixth edition): a database of point mutations and short additions and deletions.
Nucleic Acids Res. 1996 Jan 1;24(1):103-18. doi: 10.1093/nar/24.1.103.
6
Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992.
Nucleic Acids Res. 1992 May 11;20 Suppl(Suppl):2027-63. doi: 10.1093/nar/20.suppl.2027.
7
Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993.
Nucleic Acids Res. 1993 Jul 1;21(13):3075-87. doi: 10.1093/nar/21.13.3075.
8
Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations.
Br J Haematol. 2003 Feb;120(4):656-9. doi: 10.1046/j.1365-2141.2003.04141.x.
9
Factor IXBasel: a Swiss family with severe haemophilia B having a point mutation in EGF type B domain.
Nucleic Acids Res. 1991 Jan 25;19(2):409. doi: 10.1093/nar/19.2.409.
10
Novel human pathological mutations. Gene symbol: F9. Disease: Haemophilia B.
Hum Genet. 2009 Aug;126(2):332.
引用本文的文献
1
Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia.
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241275454. doi: 10.1177/10760296241275454.
2
variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project.
Res Pract Thromb Haemost. 2023 Jan 10;7(1):100036. doi: 10.1016/j.rpth.2023.100036. eCollection 2023 Jan.
3
Furin-mediated protein processing in infectious diseases and cancer.
Clin Transl Immunology. 2019 Aug 5;8(8):e1073. doi: 10.1002/cti2.1073. eCollection 2019.
4
Hemophilia B: molecular pathogenesis and mutation analysis.
J Thromb Haemost. 2015 Jul;13(7):1184-95. doi: 10.1111/jth.12958. Epub 2015 May 18.
5
Gene therapy for hemophilia: the clot thickens.
Hum Gene Ther. 2014 Nov;25(11):915-22. doi: 10.1089/hum.2014.2541.
6
Direct analysis for familial adenomatous polyposis mutations.
Mol Biotechnol. 2002 Feb;20(2):197-207. doi: 10.1385/MB:20:2:197.
7
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony.
Thromb Haemost. 2000 Aug;84(2):352-4.
8
Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.
Am J Hum Genet. 1999 Dec;65(6):1580-7. doi: 10.1086/302652.
9
Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.
Biochem J. 1997 Nov 1;327 ( Pt 3)(Pt 3):625-35. doi: 10.1042/bj3270625.
10
HpaII methyltransferase is mutagenic in Escherichia coli.
J Bacteriol. 1995 May;177(10):2950-2. doi: 10.1128/jb.177.10.2950-2952.1995.
本文引用的文献
1
Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4200-2. doi: 10.1073/pnas.80.14.4200.
2
Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene.
Nature. 1985;316(6029):643-5. doi: 10.1038/316643a0.
3
Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.
Blood. 1987 Jan;69(1):140-3.
4
Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5803-7. doi: 10.1073/pnas.83.16.5803.
5
The putative factor IX gene promoter in hemophilia B Leyden.
Blood. 1988 Sep;72(3):1074-6.
6
Genetic defect responsible for the dysfunctional protein: factor IXLong Beach.
Blood. 1988 Aug;72(2):820-2.
7
8
Blood clotting factor IX Niigata: substitution of alanine-390 by valine in the catalytic domain.
J Biochem. 1988 Dec;104(6):878-80. doi: 10.1093/oxfordjournals.jbchem.a122575.
9
Identification of a CpG mutation in the coagulation factor-IX gene by analysis of amplified DNA sequences.
Br J Haematol. 1988 Dec;70(4):411-6. doi: 10.1111/j.1365-2141.1988.tb02509.x.
10
A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism.
EMBO J. 1988 Oct;7(10):3009-15. doi: 10.1002/j.1460-2075.1988.tb03164.x.
Zotero 插件